The Ministry of Chemicals and Fertilizers on August 05, 2025, clarified regarding the ban on Paracetamol and other common medicines.
The following has been stated:
•It states that there is no ban on the widely used medicine paracetamol in India. The Central Drugs Standard Control Organisation (CDSCO) has not received any official communication or confirmation regarding such rumours. While certain Fixed Dose Combinations (FDCs) that include paracetamol with other drugs have been banned in the past, the standalone use of paracetamol remains permitted and in circulation. The list of banned combinations is publicly available on the CDSCO website.
•The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, regulates and monitors the prices of drugs under the Drugs (Prices Control) Order, 2013. It sets ceiling prices for scheduled drugs listed in the National List of Essential Medicines (NLEM) and revises them annually based on the Wholesale Price Index. For new drugs or formulations, NPPA sets retail prices, while for non-scheduled drugs, manufacturers are allowed a maximum price increase of 10% annually.
•Additionally, the Ministry has recommended an Essential Medicines List for different public healthcare facilities, ranging from 106 drugs at Sub Health Centres to 381 drugs at District Hospitals, with flexibility for states to expand the list based on local needs. To further streamline the distribution, the Medical Stores Organisation (MSO) has rate contracts for 697 drug formulations and supports 1,152 registered government indenters, who can place quarterly demands through the MSO-DVDMS software.
[Release ID: 2152591]